Skip to main content

Table 2 Characteristics of RA patients

From: Anti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis

Parameters (mean ± SD) RA patients
Positive RF, n (%) 65 (54.28%)
Positive Anti-CCP-2 Ab, n (%) 83 (69.57%)
Current DMARDs therapy, n (%) 105 (87.5%)
Current steroid therapy, n (%) 95 (79.4%)
Tender joints count (n) 16.6 ± 8.8
Swollen joints count (n) 9.8 ± 5.6
DAS28 4.18 ± 1.73
Pain VAS score 51.25 ± 20.09
HAQ score 1.6 ± 0.64
  1. Values are reported as mean ± SD.
  2. DMARDs: disease-modified anti-rheumatic drugs.
  3. DAS28: disease activity score in 28 joints.
  4. VAS: visual analog scale.
  5. HAQ: Health Assessment Questionnaire.
\